SINOLINK SECURITIES(SH:600109) Zheng Quan Zhi Xing·2025-08-07 10:14Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management to enhance fund efficiency while ensuring that it does not affect the implementation of its investment projects and guarantees the safety of the raised funds [4][6][9] Fundraising Basic Information - The company raised a total of RMB 1,007.745 million by issuing 26.45 million shares at RMB 38.10 per share, with a net amount of RMB 936.030 million after deducting issuance costs [1][2] Fund Usage Situation - The company has outlined its fundraising investment projects, with adjustments made to the amounts allocated to various projects, including: - RMB 427.68 million for the construction of facilities for the production of injectable paclitaxel polymer micelles, adjusted to RMB 330.43 million - RMB 100 million for marketing network construction - RMB 300 million for supplementary working capital and business development [3][4] Cash Management Plan - The company intends to use up to RMB 450 million of temporarily idle raised funds for cash management within a 12-month period, ensuring that it does not impact the normal operation of investment projects [4][6] - The cash management products will be limited to those with high safety, good liquidity, and a maximum term of 12 months, including principal-protected financial products, structured deposits, and large certificates of deposit [5][6] Impact on Company Operations - The planned cash management is expected to improve the efficiency of fund usage without affecting the normal operations of the company or its investment projects, potentially increasing investment returns and benefiting shareholders [4][6][9] Decision-Making Process - The board of directors approved the cash management plan, ensuring compliance with relevant regulations and that it does not harm the interests of shareholders, particularly minority shareholders [8][9]